Listed by the USPTO as BAZARGANI, ARYA AHMADI
Tech Center 3700 • Art Units: 1600 1611 1613 1614 1615 1625 3774
This examiner grants 62% of resolved cases
Arya Ahmadi Bazargani works in tech center 3700 and art unit 1600. Her record contains 8 resolved cases, with an allowance rate of 62.5%, an interview lift of 31.3%, and a median of 951 days to allowance. The limited case history means these figures should be treated as preliminary indicators.
The leading companies are Merck Patent GmbH, BASF SE, and Colgate-Palmolive Company. The leading firms are BakerHostetler, MARSHALL, GERSTEIN & BORUN LLP, and Bayramoglu Law Offices LLC. The interview figure supports considering examiner discussions in response planning, but the small record limits broader inference. Practitioners should give priority to application-specific claim analysis and use the timing figure as an initial scheduling reference.
| App # | Title | Status | Assignee |
|---|---|---|---|
| 17423592 | METHOD FOR MANUFACTURING A SOLID ADMINISTRATION FORM AND SOLID ADMINISTRATION | Non-Final OA | MERCK PATENT GMBH |
| 18681909 | AGROCHEMICAL COMPOSITION | Non-Final OA | BASF SE |
| 18769141 | TOPICAL ANALGESICS | Non-Final OA | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA |
| 18719998 | DEVICES CONTAINING PLANT-SUITABLE ACTIVE INGREDIENTS THAT ARE APPLIED TO THE SOIL OR TO THE AERIAL PARTS OF PLANTS | Final Rejection | COMPAGNIE GENERALE DES ETABLISSEMENTS MICHELIN |
| 17923182 | METHODS FOR SYNTHESIZING ANHYDROUS LACTIC ACID | Non-Final OA | Otsuka Pharmaceutical Co., Ltd. |
| 18834436 | A MECHANO-RESPONSIVE NANOFIBROUS PATCH FOR THE DELIVERY OF BIOLOGICS IN LOAD-BEARING TISSUES | Non-Final OA | THE UNITED STATES GOVERNMENT AS REPRESENTED BY THE DEPARTMENT OF VETERANS AFFAIRS |
| 18715873 | CREAMY COSMETIC COMPOSITION | Final Rejection | SHISEIDO COMPANY, LTD. |
| 18599930 | SKIN CARE COMPOSITIONS | Non-Final OA | Colgate-Palmolive Company |
| 18832464 | INJECTABLE FORMULATION CONTAINING ISOXAZOLINE DERIVATIVE | Non-Final OA | LG CHEM, LTD. |
| 18548690 | ORAL THIN FILM | Final Rejection | LTS LOHMANN THERAPIE-SYSTEME AG |
| 18860868 | CORRALLING AMPHIPATHIC PEPTIDE COLLOIDS | Non-Final OA | KANSAS STATE UNIVERSITY RESEARCH FOUNDATION |
IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.
Build Your Strategy62.5% of resolved applications examined by Arya Ahmadi Bazargani were allowed (8 resolved cases), compared with 37.3% across Art Unit 1600 over the last five years.
This examiner's interview lift is +31.3 percentage points: the difference in allowance rate between resolved applications that had an examiner interview and those that did not.
Applications allowed by Arya Ahmadi Bazargani took 951 days on average from filing to allowance.
Arya Ahmadi Bazargani examines applications in Art Unit 1600 in Tech Center 3700 (Medical Devices & Mechanical Engineering).